Corporate Banner
Satellite Banner
Crystallography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Agilent Technologies Appoints Ron Nersesian President and COO

Published: Thursday, November 15, 2012
Last Updated: Thursday, November 15, 2012
Bookmark and Share
The company's board of directors has appointed Ron Nersesian Agilent president and chief operating officer, effective immediately.

Nersesian has been executive vice president and chief operating officer since November 2011.

Nersesian, 53, will continue to be responsible for Agilent's Chemical Analysis (CAG), Life Sciences (LSG), Electronic Measurement (EMG), and Agilent Order Fulfillment (AOF) businesses, with the presidents of those groups reporting to him. Nersesian will continue to report to William (Bill) Sullivan, who remains chief executive officer.

Nersesian first joined Hewlett-Packard Co., Agilent's predecessor company, in 1984. Since then he has served in various management positions, including president of the electronic measurement business from 2009 to 2011.

Nersesian holds a bachelor's degree in electrical engineering from Lehigh University and an MBA from New York University, Stern School of Business.

"Ron is an outstanding global business leader," said Sullivan. "He transformed EMG when he headed that business, resulting in record profitable growth across current and emerging markets."

"Over the past year as COO, Ron made significant strides in increasing the profitability of our life science and chemical analysis businesses even as we navigated through a difficult economy," said Sullivan.

Sullivan added, "Ron's appointment as president and COO is an opportunity for Agilent to further leverage the skills of an executive with an exceptional record of business growth, cost improvements and superior return on invested capital."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 4,000+ scientific posters on ePosters
  • More than 5,300+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Agilent Supports International Year of Crystallography
2014 partnership with international union of crystallography aimed at educating, inspiring young scientists.
Monday, January 27, 2014
Agilent Reports Fourth-Quarter Results
Agilent Technologies reported orders up 4 percent over one year ago to $1.83 billion with revenues of $1.72 billion, down 3 percent compared with one year ago.
Monday, November 18, 2013
Agilent Recognized as 2013 Laboratory Analytical Instrumentation Company of the Year in China
The company ranked highest in industry for leadership, growth, innovation and customer service by Frost & Sullivan.
Tuesday, August 20, 2013
Agilent Technologies Prices $400 Million of Senior Notes
Agilent intends to use the net proceeds from the offering for general corporate purposes, which will include the repayment of its 4.45 percent senior notes due in September 2012.
Tuesday, September 11, 2012
Agilent Technologies Reports Third-Quarter 2012 Results
Revenues were $1.72 billion for the third fiscal quarter ended July 31, 2012, 2 percent above one year ago.
Thursday, August 16, 2012
Agilent Technologies Ships 300th X-Ray Crystallography System
Recipient is University of Oxford’s Chemical Crystallography Laboratory.
Monday, September 06, 2010
Scientific News
Human Astrovirus Structure Could Lead to Therapies, Vaccines
Study shows where neutralizing antibody binds to human astrovirus, a leading cause of viral diarrhoea in children, elderly, and the immune-compromised.
Drug Design Strategy to Improve Breast Cancer Treatment
Scientists develop novel structure-based drug design strategy aimed at altering the basic landscape of hormone-driven breast cancer treatment.
Crystals, Super Magnets in Drug Discovery
Scientists have produced larger superparamagnetic crystals that could revolutionise drug delivery.
Peer Review is in Crisis, But Should be Fixed, Not Abolished
After the time to get the science done, peer review has become the slowest step in the process of sharing studies, and some scientists have had enough.
Snapshots of Chemical Flipping a Biological Switch
X-ray laser gets first real-time snapshots of a chemical flipping a biological switch, opening new path to understanding how RNA works.
Uncovering Elusive Proteins
Researchers have determined the complete structure of elusive proteins, known as tetraspanins, for the first time.
Cannabinoid Receptor Structure Revealed
Scientists provided a detailed view of the primary molecule through which cannabinoids exert their effects on the brain. The findings might help guide the design of more targeted medicines with fewer side effects.
Alzheimer’s Treatment Moves a Step Closer
Merck scientists have reported the discovery of verubecestat, a structurally unique, orally bioavailable small molecule that has been shown to target the most visible sign of the disease in the brain.
Study Unocovers Cancer-Linked Protein’s Associates
Researchers have developed a new list of nearly 100 potential partners of a cancer-linked enzyme by studying its interactions with other proteins.
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
4,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,300+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!